Morten Otto Alexander Sommer,Ramus Vendler Toft-Kehler,Daniel Jean Jacques Simon
申请号：
US16589699
公开号：
US20200093839A1
申请日:
2019.10.01
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to halogenated salicylanilides, or pharmaceutically acceptable salts or esters thereof, for use in the treatment of an infection in a subject caused by Clostridium bacteria, particularly a C. difficile infection. The halogenated salicylanilides are expected to be useful in the treatment of C. difficile associated diseases including C. difficile associated diarrhoea and C. difficile associated colitis.
